Evidence map›Paper›PMID 39015084›Full record

ArticleCancer research communications2024

Membrane-bound Heat Shock Protein mHsp70 Is Required for Migration and Invasion of Brain Tumors.

Maxim Shevtsov, Danila Bobkov, Natalia Yudintceva, Ruslana Likhomanova, Alexander Kim, Evegeniy Fedorov, Viacheslav Fedorov, Natalia Mikhailova, Elena Oganesyan, Sergey Shabelnikov and 15 more

Abstract read
In one paragraph

Article in Cancer research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. ThemicroPublication biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Maxim ShevtsovKlinikum Rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0002-8539-2239
Danila Bobkov *Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-0358-9266
Natalia Yudintceva *Personalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-7357-1571
Ruslana LikhomanovaPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0001-8347-7274
Alexander KimPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-6219-7270
Evegeniy FedorovPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0001-7862-9341
Viacheslav FedorovPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-0239-7473
Natalia MikhailovaPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-2195-1038
Elena OganesyanPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0009-0004-8691-7887
Sergey ShabelnikovInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.ORCID 0000-0002-5693-5310
Oleg RozanovPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0009-0006-3503-3445
Timur GaraevPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0009-0000-9448-0946
Nikolay AksenovInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.ORCID 0000-0002-2549-9149
Alla ShatrovaInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.ORCID 0000-0002-4410-9580
Artem TenSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok, Russia.ORCID 0009-0008-6219-5970
Anastasiya NechaevaPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0001-9898-5925
Daria GoncharovaPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0009-0002-1176-4519
Rustam ZiganshinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences (RAS), Moscow, Russia.ORCID 0000-0002-7931-519X
Anastasiya LukachevaPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-8007-4872
Daria SitovskayaPolenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0001-9721-3827
Alexey UlitinPolenov Neurosurgical Institute, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0002-8343-4917
Emil PitkinWharton School, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0003-7817-8255
Konstantin SamochernykhPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0003-0350-0249
Evgeny ShlyakhtoPersonalized Medicine Centre, Almazov National Medical Research Centre, St. Petersburg, Russia.ORCID 0000-0003-2929-0980
Stephanie E CombsKlinikum Rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0002-5233-1536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular chaperones, especially 70 kDa heat shock protein, in addition to their intracellular localization in cancer cells, can be exposed on the surface of the plasma membrane. We report that the membrane-associated chaperone mHsp70 of malignant brain tumors is required for high migratory and invasive activity of cancer cells. Live-cell inverted confocal microscopy of tumor samples from adult (n = 23) and pediatric (n = 9) neurooncologic patients showed pronounced protein expression on the membrane, especially in the perifocal zone. Mass spectrometry analysis of lipid rafts isolated from tumor cells confirmed the presence of the protein in the chaperone cluster (including representatives of other families, such as Hsp70, Hsc70, Hsp105, and Hsp90), which in turn, during interactome analysis, was associated with proteins involved in cell migration (e.g., Rac1, RhoC, and myosin-9). The use of small-molecule inhibitors of HSP70 (PES and JG98) led to a substantial decrease in the invasive potential of cells isolated from a tumor sample of patients, which indicates the role of the chaperone in invasion. Moreover, the use of HSP70 inhibitors in animal models of orthotopic brain tumors significantly delayed tumor progression, which was accompanied by an increase in overall survival. Data demonstrate that chaperone inhibitors, particularly JG98, disrupt the function of mHsp70, thereby providing an opportunity to better understand the diverse functions of this protein and offer aid in the development of novel cancer therapies. SIGNIFICANCE: Membrane-bound mHsp70 is required for brain tumor cell migration and invasion and therefore could be employed as a target for anticancer therapies.

Indexed as

Brain NeoplasmsCell MovementHSP70 Heat-Shock ProteinsNeoplasm InvasivenessAdultAnimalsCell Line, TumorCell MembraneFemaleHumansMaleMembrane MicrodomainsMiceHSP70 Heat-Shock Proteins

Identifiers

PMID39015084
PMCPMC11317918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.